Kinetic compartmental analysis of carnitine metabolism in the human carnitine deficiency syndromes. Evidence for alterations in tissue carnitine transport.
Open Access
- 1 March 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 73 (3) , 857-867
- https://doi.org/10.1172/jci111281
Abstract
The human primary carnitine deficiency syndromes are potentially fatal disorders affecting children and adults. The molecular etiologies of these syndromes have not been determined. In this investigation, we considered the hypothesis that these syndromes result from defective transport of carnitine into tissues, particularly skeletal muscle. The problem was approached by mathematical modeling, by using the technique of kinetic compartmental analysis. A tracer dose of L-[methyl-3H]carnitine was administered intravenously to six normal subjects, one patient with primary muscle carnitine deficiency (MCD), and four patients with primary systemic carnitine deficiency (SCD). Specific radioactivity was followed in plasma for 28 d. A three-compartment model (extracellular fluid, muscle, and "other tissues") was adopted. Rate constants, fluxes, pool sizes, and turnover times were calculated. Results of these calculations indicated reduced transport of carnitine into muscle in both forms of primary carnitine deficiency. However, in SCD, the reduced rate of carnitine transport was attributed to reduced plasma carnitine concentration. In MCD, the results are consistent with an intrinsic defect in the transport process. Abnormal fluctuations of the plasma carnitine, but of a different form, occurred in MCD and SCD. The significance of these are unclear, but in SCD they suggest abnormal regulation of the muscle/plasma carnitine concentration gradient. In 8 of 11 subjects, carnitine excretion was less than dietary carnitine intake. Carnitine excretion rates calculated by kinetic compartmental analysis were higher than corresponding rates measured directly, indicating degradation of carnitine. However, we found no radioactive metabolites of L-[methyl-3H]carnitine in urine. These observations suggest that dietary carnitine was metabolized in the gastrointestinal tract.This publication has 34 references indexed in Scilit:
- Carnitine deficiency presenting as familial cardiomyopathy: A treatable defect in carnitine transportThe Journal of Pediatrics, 1982
- A CRITIQUE OF COMPARTMENTAL ANALYSISAnnual Review of Biophysics and Bioengineering, 1981
- Increased acetyl carnitine in rat skeletal muscle as a result of high‐intensity short‐duration exerciseFEBS Letters, 1981
- Systemic carnitine deficiency simulating recurrent Reye syndromeThe Journal of Pediatrics, 1980
- Stoffwechsel des l-Carnitins bei EnterobakterienJournal of Basic Microbiology, 1980
- Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in cultureBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- Carnitine movement across muscle cell membranes. Studies in isolated rat muscleBiochimica et Biophysica Acta (BBA) - Biomembranes, 1977
- A simple method for preparation of methyl-labelled (—) carnitineBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970
- Formation of trimethylamine from dl-carnitine by Serratia marcescensBiochimica et Biophysica Acta (BBA) - General Subjects, 1966
- THE MEASUREMENT OF EXTRACELLULAR FLUID IN MAN BY MEANS OF A CONSTANT INFUSION TECHNIQUE 1Journal of Clinical Investigation, 1949